Dupilumab for COPD with Elevated Eosinophil Counts

MeSH terms

• Antibodies, Monoclonal, Humanized* / administration & dosage
• Antibodies, Monoclonal, Humanized* / economics
• Clinical Trials, Phase III as Topic
• Cost-Benefit Analysis
• Drug Therapy, Combination / economics
• Drug Therapy, Combination / methods
• Eosinophilia* / blood
• Eosinophilia* / diagnosis
• Eosinophilia* / drug therapy
• Eosinophilia* / etiology
• Eosinophils / drug effects
• Glucocorticoids / administration & dosage
• Glucocorticoids / economics
• Humans
• Leukocyte Count
• Pulmonary Disease, Chronic Obstructive* / blood
• Pulmonary Disease, Chronic Obstructive* / congenital
• Pulmonary Disease, Chronic Obstructive* / diagnosis
• Pulmonary Disease, Chronic Obstructive* / drug therapy
• Quality of Life
• Randomized Controlled Trials as Topic
• Treatment Outcome